Posted on: 28-May-2026
Treatment with ixekizumab plus tirzepatide achieves greater disease control, physical function and weight loss vs. monotherapy in patients with psoriatic arthritis and obesity, according to data published in Arthritis & Rheumatology.
Source: Healio
Read more